findmyKOL

Jonathan Meyer, MD

Enriched profile

Clinical Professor (Voluntary), Department of Psychiatry · University of California, San Diego (UC San Diego)

ORCIDNone on fileNPI↗
Region🇺🇸 San Diego, CA · West · United StatesSpecialtyPsychiatryFocusSchizophrenia
Active KOLLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH funding2005–2010Why? →

Jonathan Meyer is Clinical Professor (Voluntary), Department of Psychiatry at University of California, San Diego (UC San Diego). ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 31 Aug 2026

Jonathan M. Meyer, MD, is Clinical Professor (Voluntary), Department of Psychiatry at University of California, San Diego (UC San Diego). The public record shows 15 publications with 2,482 citations (h-index 10), centered on Schizophrenia. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 25 companies, 3 NIH-funded awards (2005–2010).

  • Top research focus: Schizophrenia
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Schizophrenia2 trialsInsulin Resistance1 trialMetabolic Syndrome1 trial

Research focus

OpenAlex concept fingerprint
Schizophrenia

Drugs & molecules

across trials, industry payments and publications
Lybalvigeneric · Olanzapine / samidorphanClinical trials—Industry payments929Publications—Aristadageneric · Aripiprazole lauroxilClinical trials—Industry payments820Publications—Caplytageneric · LumateperoneClinical trials—Industry payments365Publications—
9 more drug records behind the reveal.Reveal →

Works with

trial sponsors and companies reporting payments
Alkermes, Inc.Clinical trials—Industry payments400Neurocrine BioSciences, Inc.Clinical trials—Industry payments305Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments303
21 more company records behind the reveal.Reveal →

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2005–2010

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Aug 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

1 more trial record behind the reveal.Reveal →

Industry payments

Updated 31 Aug 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

51 more payment records behind the reveal.Reveal →
View the CMS Open Payments record ↗

NIH funding

Updated 31 Aug 2026

3 NIH research awards on record, funded 2005–2010 per NIH RePORTER. The latest:

10 more award records behind the reveal.Reveal →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 31 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jonathan-meyer-md-7d907b8a

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Jonathan-Meyer-5

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    psychopharmacologyinstitute.com/author/jonathan-m-meyer-878

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychopharmacologyinstitute.com ↗
  • Other

    hmpglobalevents.com/faculty/psych-congress-np-institute/920

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpglobalevents.com ↗
  • Other

    mdedge.com/podcasts/psychcast/lumateperone-treating-schizophrenia-dr-jonathan-meyer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdedge.com ↗
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 31 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Chief Editor

    "Medical Illness and Schizophrenia" (2nd edition)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
  • Deputy Editor

    Current Psychiatry

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curesz.org ↗
  • Chair

    CLOSZE Panel (Clozapine in Schizophrenia Experts)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curesz.org ↗
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • AJMC

    "AMCP 2011: Interview with Dr. Jonathan Meyer of the University of California at San Diego"

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
  • Medscape InDiscussion

    "Treatment-Resistant Schizophrenia," S2 Episode 1

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
  • HCPLive video interview

    "Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.